Tenon Medical, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Tenon Medical, Inc. (TNON) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $59.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $59.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $59.00K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $59.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $59.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $59.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $59.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $59.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $59.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |